Recombinant CD52 (Alemtuzumab Biosimilar) anticorps

N° du produit ABIN7795101

L’anticorps Souris Monoclonal anti-CD52 (Alemtuzumab Biosimilar) a été validé pour FACS et in vivo. Il convient pour détecter CD52 (Alemtuzumab Biosimilar) dans des échantillons de Humain.

Aperçu rapide pour Recombinant CD52 (Alemtuzumab Biosimilar) anticorps (ABIN7795101)

Antigène: CD52 (Alemtuzumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CD52 (Alemtuzumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Classe de qualité: Research Grade

Détail du produit anti-CD52 (Alemtuzumab Biosimilar) anticorps

Expression System: Mammalian cells

Fonction: Alemtuzumab Biosimilar, Human CD52 Monoclonal Antibody

Attributs du produit: Alemtuzumab Biosimilar uses the same protein sequences as the therapeutic antibody alemtuzumab. Alemtuzumab is a medication used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis. In CLL, it has been used as both a first line and second line treatment. In MS it is generally only recommended if other treatments have not worked. It is given by injection into a vein. It is a monoclonal antibody that binds to CD52, a protein present on the surface of mature lymphocytes, but not on the stem cells from which these lymphocytes are derived. After treatment with alemtuzumab, these CD52-bearing lymphocytes are targeted for destruction.

Purification: Protein A or G affinity column

Pureté: >95 % by reducing SDS-PAGE

niveau d'endotoxine: < 1 EU per 1 mg of the protein by the LAL method

Immunogène: Human CD52

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: > 3 mg/mL

Stock: 4 °C,-20 °C

Stockage commentaire: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Détails sur CD52 (Alemtuzumab Biosimilar)

Antigène: CD52 (Alemtuzumab Biosimilar)

Autre désignation: Alemtuzumab Biosimilar

Classe de substances: Biosimilar